Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Acute spinal cord injury: pharmacotherapy and drug development perspectives.

Blight AR, Zimber MP.

Curr Opin Investig Drugs. 2001 Jun;2(6):801-8. Review.

PMID:
11572660
2.

Clinical applications of pharmacologic therapies for spinal cord injury.

Zeidman SM, Ling GS, Ducker TB, Ellenbogen RG.

J Spinal Disord. 1996 Oct;9(5):367-80. Review.

PMID:
8938604
3.

Pathophysiology and pharmacologic treatment of acute spinal cord injury.

Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR.

Spine J. 2004 Jul-Aug;4(4):451-64. Review.

PMID:
15246307
4.

Neuroprotection after spinal cord injury: state of the science.

Segatore M, Way C.

SCI Nurs. 1997 Mar;14(1):8-18. Review.

PMID:
9165951
5.

Summary statement: the Sygen(GM-1 ganglioside) clinical trial in acute spinal cord injury.

Fehlings MG, Bracken MB.

Spine (Phila Pa 1976). 2001 Dec 15;26(24 Suppl):S99-100. No abstract available.

PMID:
11805615
6.

Update on the treatment of spinal cord injury.

Baptiste DC, Fehlings MG.

Prog Brain Res. 2007;161:217-33. Review.

PMID:
17618980
7.

New pharmacologic approaches to acute spinal cord injury.

Rhoney DH, Luer MS, Hughes M, Hatton J.

Pharmacotherapy. 1996 May-Jun;16(3):382-92. Review.

PMID:
8726596
8.

Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury.

Geisler FH, Dorsey FC, Coleman WP.

Ann Emerg Med. 1993 Jun;22(6):1041-7. Review.

PMID:
8503523
9.

Neuroprotective effect of Scutellaria baicalensis on spinal cord injury in rats.

Yune TY, Lee JY, Cui CM, Kim HC, Oh TH.

J Neurochem. 2009 Aug;110(4):1276-87. doi: 10.1111/j.1471-4159.2009.06214.x. Epub 2009 Jun 10.

10.

New drugs for improving injury outcome in spinal cord injuries.

Werner PC.

West J Med. 1997 Apr;166(4):271-2. No abstract available.

11.

Acute spinal cord injury, part II: contemporary pharmacotherapy.

Dumont RJ, Verma S, Okonkwo DO, Hurlbert RJ, Boulos PT, Ellegala DB, Dumont AS.

Clin Neuropharmacol. 2001 Sep-Oct;24(5):265-79. Review.

PMID:
11586111
12.
13.

Promising pharmacological agents in the management of acute spinal cord injury.

Seidl EC.

Crit Care Nurs Q. 1999 Aug;22(2):44-50. Review.

PMID:
10646442
14.

Pharmacological neuroprotective therapy for acute spinal cord injury: state of the art.

Martiñón S, Ibarra A.

Mini Rev Med Chem. 2008 Mar;8(3):222-30. Review.

PMID:
18336342
15.

Blockade of sodium channels by phenytoin protects ultrastructure and attenuates lipid peroxidation in experimental spinal cord injury.

Kaptanoglu E, Solaroglu I, Surucu HS, Akbiyik F, Beskonakli E.

Acta Neurochir (Wien). 2005 Apr;147(4):405-12; discussion 412.

PMID:
15696267
16.

Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats.

Okutan O, Solaroglu I, Beskonakli E, Taskin Y.

J Clin Neurosci. 2007 Apr;14(4):364-8. Epub 2007 Jan 22.

PMID:
17236773
17.

Evaluation of time-dependent spread of tissue damage in experimental spinal cord injury by killed-end evoked potential: effect of high-dose methylprednisolone.

Fukaya C, Katayama Y, Kasai M, Kurihara J, Maejima S, Yamamoto T.

J Neurosurg. 2003 Jan;98(1 Suppl):56-62.

PMID:
12546389
18.
19.

Non-surgical management of spinal cord injury.

Legos JJ, Gopez JJ, Young WF.

Expert Opin Investig Drugs. 2002 Apr;11(4):469-82. Review. Erratum in: Expert Opin Investig Drugs 2002 Nov;11(11):1693.

PMID:
11922856
20.

Limiting spinal cord injury by pharmacological intervention.

Priestley JV, Michael-Titus AT, Tetzlaff W.

Handb Clin Neurol. 2012;109:463-84. doi: 10.1016/B978-0-444-52137-8.00029-2. Review.

PMID:
23098731

Supplemental Content

Support Center